 lecture Beta-cells type II mellitus immunoassays insulin significant quantities hormone non-insulin-dependent type II yr debate beta-cell abnormality etiological role syndrome Early efforts adequacy islet beta-cell function obesity associated insulin resistance major variables glucose insulin synthesis secretion islet signals substrates hormones neural factors obesity glucose account clear patients hyperglycemia abnormal islet function Type II defect first-phase acute glucose-induced insulin secretion deficiency ability glucose islet nonglucose beta-cell secretagogues hyperglycemia compensates defective glucose potentiation normal basal insulin levels insulin responses secretagogues defect first-phase glucose-induced insulin release development hyperglycemia first-phase glucose-induced insulin secretion defective progressive islet failure glucose levels basal second-phase insulin output relationship islet function plasma glucose steeply curvilinear loss beta-cell function time diagnostic level mg/dl new steady state glucose overproduction inefficient utilization Insulin resistance present patients contributes hyperglycemia glucose levels compensation Decompensation absolute hypoinsulinemia occur renal threshold glucose prevents elevation glucose etiology islet beta-cell lesion hypothesis basal hyperproinsulinemia islet amyloid deposits pancreas type II recent discovery islet amyloid polypeptide IAPP amylin major constituent islet amyloid deposits hypothesis pro-IAPP proinsulin processing mature peptide secretion abnormal processing secondary conjunction defects hormone secretion lead progressive accumulation intracellular IAPP pro-IAPP cats monkeys humans intracellular fibrils amyloid deposits loss beta-cell mass ABSTRACT TRUNCATED AT WORDS